News & Analysis on Clinical Trial Services & Contract Research And Development
Indiana’s new “religious freedom” law is discriminatory and will make it harder to attract the staff needed to develop drugs for cancer and Alzheimer's disease according to Eli Lilly.
UK-based risk-sharing CRO Ergomed has opened its first Asian office in Taiwan to strengthen its clinical research and consultancy presence in Asia.
Employee safety is a focus for drugmakers and a growing market for the preclinical testing services sector according to Huntingdon Life Sciences.
In another sign that early phase research demand is picking up, North Carolina-based CRO PRA Health Sciences (PRA) is increasing its Phase I clinical footprint in the US and Russia.
Biorasi has become the latest CRO to ink a deal to use Medidata's Rave cloud-based clinical trial management technology.
Sun Pharmaceutical Industries has completed its $4bn (€3.7bn) acquisition of Ranbaxy after receiving the thumbs up from the US Federal Trade Commission (FTC).